Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries
about
Screening for chronic comorbid diseases in people with HIV: the need for a strategic approachImpact of Socioeconomic Inequality on Access, Adherence, and Outcomes of Antiretroviral Treatment Services for People Living with HIV/AIDS in VietnamHigh prevalence of illicit drug use in men who have sex with men with HIV-1 infection in JapanHousing status and the health of people living with HIV/AIDSDynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART.Data Resource Profile: The Human Mortality Database (HMD).Hospital admissions for HIV-infected prisoners in Italy.HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC).Prevalence and Risk Factors of Mortality among Adult HIV Patients Initiating ART in Rural Setting of HIV Care and Treatment Services in North Western Tanzania: A Retrospective Cohort StudyVirological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment.Mortality by causes in HIV-infected adults: comparison with the general population.Evaluating the Impact of a HIV Low-Risk Express Care Task-Shifting Program: A Case Study of the Targeted Learning RoadmapRecent key advances in human immunodeficiency virus medicine and implications for ChinaRisk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.Quality of life outcomes of antiretroviral treatment for HIV/AIDS patients in Vietnam.Trends in all-cause mortality during the scale-up of an antiretroviral therapy programme: a cross-sectional study in Lusaka, Zambia.Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.Cost-effectiveness of the third-agent class in treatment-naive human immunodeficiency virus-infected patients in Portugal.Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?Death and seeking alternative therapy largely accounted for lost to follow-up of patients on ART in northwest Ethiopia: a community tracking survey.Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region.Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting.All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010.Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort studyEstimating the impact of antiretroviral therapy: regional and global estimates of life-years gained among adultsImpact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis.Short Communication: Viral Suppression Is Associated with Increased Likelihood of Colorectal Cancer Screening Among Persons Living with HIV/AIDS.Switching antiretroviral therapy to minimize metabolic complications.Activation of persons living with HIV for treatment, the great study.Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment.Commentary: Questioning the HIV-AIDS Hypothesis: 30 Years of DissentIntellectual Impairment in Patients with Newly Diagnosed HIV Infection in Southwestern Nigeria.Coinfection by Hepatitis C Is Strongly Associated with Abnormal CD4/CD8 Ratio in HIV Patients under Stable ART in Salvador, Brazil.The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject DrugsTrends in hospital deaths among human immunodeficiency virus-infected patients during the antiretroviral therapy era, 1995 to 2011'Waiting at the dinner table for scraps': a qualitative study of the help-seeking experiences of heterosexual men living with HIV infection.
P2860
Q26866452-0491F6A8-8819-49B6-9F96-2D844C0CEC17Q28354164-3ABC6304-C853-4968-81D5-941783EA97CCQ28536725-B2978181-975D-4D01-A433-2A1F0E6C6E36Q30421169-6C283901-51FF-4B8A-95B1-B79E7C09DE4BQ30558310-FAEEA8E0-F642-4E55-90F6-87419A4E0FC8Q30976573-727FF767-FE7D-4341-9D3F-C906B76B14D4Q33442442-0EA19C12-9484-4DB3-BC37-F1085FA3FEF9Q33618542-095776CC-442E-481A-B8FD-4265E5ACE9D3Q33736040-31E22D70-7B43-4BBB-B944-9BEC52C77B53Q33862338-445D079E-DD72-4A51-99EB-3BF9C0AEFD70Q33880782-001C1A1E-63DB-4593-939A-ABB4D7E3BFE6Q33898621-EEAE662B-C41D-4D46-B458-84BF6FDFB1C1Q33922137-6E58CE2C-4780-40EB-BD79-2AF8670B862FQ33933502-234C8C7D-B0DB-4768-BBEA-FE0BFC5F1B45Q33962303-DE626080-F174-4034-962B-F4D470090EF3Q34113515-C9C37BA3-BC80-4D50-8F77-2FC0A6C33032Q34387643-1A1E0167-71BE-4655-AD0A-C5BBDFCEEEEBQ34399340-6CD24020-08D1-40DD-8E97-023F941A6879Q34405742-F51F0A42-A0E4-4F99-8FF9-8DE3AB7A7871Q34427423-29D66898-D462-4235-B981-E574EE258ACCQ34455423-37E1C30A-BAA0-4ACF-9CF5-B019CD222B37Q34634820-4F2C9288-6726-47BD-B9FE-130DD33A7414Q34804309-2647C0BB-02FF-46DD-BAC6-AEF08CB2A9F2Q34823231-671C3931-9AFC-43B7-98AE-DB7B0B534F6EQ34902580-AE3948B1-395E-483A-BA15-128771EE2285Q34958573-FB55ABA0-D39D-48F6-A13E-D6CBF0DDB5B0Q35189562-EBB40E6A-1CC2-4714-93A7-CA868E9654EBQ35214935-8BD6ACEC-119E-4392-80A8-158DB95ADB78Q35316315-B6812D63-AED7-41B0-B0F6-4B3837BC178AQ35544688-88B29114-C9BA-45CC-9B07-C58791141B63Q35589825-8469FDAD-AB96-41D2-A248-74C5B1E163D9Q35608074-6F36CF8D-13E7-4703-992C-FBD61C199E33Q35810920-102D952B-E67A-4588-A00E-BF867ECA4F81Q35856799-52D0713C-2BCA-409A-A236-EEB48B99F8B8Q35925705-DCC6E9E3-B654-4DBA-A45F-E45E2837A7D1Q35941606-1CBF170F-3322-4449-8437-A6758C1710D2Q36015283-007A6BFA-7E9F-48AD-BF14-9A3434FC9107Q36030512-5F27CCE9-64DD-4ECB-A0AB-49ADAE338AE4Q36030846-75F418AF-8008-47AE-A46C-42480A5388C9Q36107948-880DAB31-49EC-4041-A46A-BF9B6C42DBB5
P2860
Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Mortality of HIV-infected pati ...... nine industrialized countries
@ast
Mortality of HIV-infected pati ...... nine industrialized countries
@en
type
label
Mortality of HIV-infected pati ...... nine industrialized countries
@ast
Mortality of HIV-infected pati ...... nine industrialized countries
@en
prefLabel
Mortality of HIV-infected pati ...... nine industrialized countries
@ast
Mortality of HIV-infected pati ...... nine industrialized countries
@en
P2093
P2860
P50
P921
P356
P1476
Mortality of HIV-infected pati ...... nine industrialized countries
@en
P2093
Amy Justice
Antiretroviral Therapy Cohort Collaboration
Charlotte Lewden
Fiona Lampe
Frank de Wolf
Jordi Casabona
Ross Harris
Sholmo Staszewski
P2860
P304
P356
10.1093/IJE/DYP306
P50
P577
2009-10-09T00:00:00Z